Home   |   About Us   |   Investors   |   Careers   |   Product Experience   |   Contact Us

Overview

The UroLume® Urethral Stent is an implantable device for men that is intended to relieve urinary obstruction resulting from:
  • Recurrent bulbar urethral strictures —UroLume relieves urinary obstruction and also minimizes the recurrence of strictures.
  • Enlarged prostate or benign prostatic hyperplasia (BPH)—UroLume is minimally invasive and effective treatment option to prostate surgery.
  • Detrusor external sphincter dyssynergia (DESD)—UroLume offers relief to patient that suffer from urinary obstruction due to DESD, which frequently accompanies spinal cord injury.

Benefits of UroLume for BPH

  • Immediately improves the flow of urine¹
  • Provides immediate benefits and has been clinically proven maintain those results over the long term
  • No catheter required after most procedures¹
  • Becomes fully incorporated within the body¹
  • Allows for a full range of endoscopic procedure¹·²
  • Allows normal erections without retrograde ejaculations (into bladder instead of out of urethra) ³
  • Fully compatible with all tissue imaging systems (MRI, X-ray and Ultrasound)
  • Does not interfere with serum prostate-specific antigen levels¹
  • The procedure is easy and safe and can be done under local anesthesia²

1. Tekchandani AH, Oesterling JE. The UroLume endoprosthesis: indications, placements, and results. Cotemporary Urology Oct 1996 (no pages listed)
2. Masood S, Djaladat H, Kouriefs C, Keen M, Palmer JH. The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia. BJU Int Dec. 2004 v. 94(9)p. 1271-4.
3. Milroy E. Permanent prostate stents. J Endourology 1991 v. 5(2) p. 75-78.